What is Synergy?
Synergy CHC operates as an omni-channel consumer health and beauty enterprise, headquartered in Westbrook, Maine. The company's diverse product portfolio spans brain health supplements, health teas, and anti-aging creams, catering to a broad consumer base seeking wellness and cosmetic solutions. Its strategic positioning in the health and beauty sector is further solidified by its comprehensive product offerings.
How much funding has Synergy raised?
Synergy has raised a total of $10M across 1 funding round:
Debt
$10M
Debt (2017): $10M with participation from Knight Therapeutics
Key Investors in Synergy
Knight Therapeutics
Knight Therapeutics is a leading pan-American specialty pharmaceutical company focused on providing innovative therapies in Canada and Latin America. The company develops and commercializes a range of pharmaceutical products, including the recently launched JORNAY PM, an extended-release formulation of methylphenidate. Knight Therapeutics aims to address the unique healthcare needs of patients in these regions. Their target clients include healthcare providers and patients requiring specialized medications.
What's next for Synergy?
The recent major strategic investment signals a pivotal phase for Synergy CHC, likely aimed at accelerating market penetration, expanding its product development pipeline, and enhancing its omni-channel distribution capabilities. This infusion of capital is expected to fuel further innovation in its health and beauty offerings, potentially exploring new formulations and consumer engagement strategies to solidify its market leadership.
See full Synergy company page
